When runway is precious and efficiency is paramount, look to Australia to get your phase 1 study started sooner, completed promptly, and done less expensively. You can begin the FDA IND process with your phase 1 in process and human data in hand. Australia will help you get a jumpstart on the coming biotech boom.
Join this Australian Clinical Trials Roadshow and meet experts from a leading Phase 1 Unit (Nucleus Network), CRO (Avance Clinical) Bioanalytical Lab (Resolian), and R&D Incentive Consultant (RDI Partners) Discover why Australia is a game-changer in early phase clinical trials.
